Your Unread Messages in Pharma News
See All >> Messages include industry-sponsored communications and special communications from MDLinx41 Baxter receives marketing authorization for hyqvia in European Union Full Text Baxter, May 23, 2013
42 NY hospital receives AHA living the vision award Full Text American Hospital Association News, May 23, 2013
43 Covidien announces clinical trial data showing endoscopic ablation therapy eliminates precancerous esophageal tissue and significantly reduces disease progression Full Text Covidien, May 23, 2013
44 Merck statement on fda advisory committee meeting for suvorexant Full Text Merck, May 23, 2013
45 New data demonstrate significant and sustained blood pressure reduction with boston scientific vessix renal denervation system Full Text Boston Scientific, May 23, 2013
46 Boston scientific promus premier and synergy drug-eluting stent systems provide exceptional safety and efficacy data Full Text Boston Scientific, May 23, 2013
47 Abbott to present at deutsche bank 38th annual health care conference Full Text Abbott, May 23, 2013
48 Roche presents new, fully automated lab solution at Europe's largest diagnostics conference Full Text Roche, May 23, 2013
49 AHA AD, video spotlight essential role of hospitals, health systems Full Text American Hospital Association News, May 23, 2013
50 Modern family star julie bowen calls on communities to raise their hand for anaphylaxis awareness in nationwide competition Full Text Mylan, May 23, 2013
51 Wireless pill bottle wins healthcare innovation world cup Full Text Boehringer Ingelheim, May 23, 2013
52 Bristol-myers squibb advances leadership position in immuno-oncology with data to be presented at 2013 American Society of Clinical Oncology (asco) Annual Meeting Full Text Bristol Myers-Squibb, May 23, 2013
53 Bristol-myers squibb announces intention to voluntarily delist preferred stock Full Text Bristol Myers-Squibb, May 23, 2013
54 Bristol-myers squibb to hold investor teleconference to discuss ASCO highlights Full Text Bristol Myers-Squibb, May 23, 2013
55 Elan's response to royalty pharma announcement Full Text Elan, May 23, 2013
56 Elan announces proposed offering of us$800.0 million in aggregate principal amount of senior notes due 2021 Full Text Elan, May 23, 2013
57 New study shows effect of neupro (rotigotine transdermal system) on cardiovascular measures in patients with restless legs syndrome Full Text UCB, May 23, 2013
58 Agenus announces initiation of enrollment in nci-sponsored randomized trial of prophage g-200 vaccine with avastin in treatment of brain tumors Full Text Agenus, May 23, 2013
59 Salix pharmaceuticals outlines data presentations at digestive disease week 2013 Full Text Salix Pharmaceuticals, May 23, 2013
60 Patheon announces changes to its commercial operations structure Full Text Patheon, May 23, 2013
1 Astellas pharma global development announces management reorganization Astellas, April 3, 2013 Free full text
2 Abbott Initiates Voluntary Recall of FreeStyle InsuLinx Blood Glucose Meters in the United States Abbott, April 16, 2013 Free full text
3 Warner Chilcott Announces FDA Approval of New Oral Contraceptive Warner Chilcott, April 25, 2013 Free full text
4 FDA alerts providers to mattress cover safety risks American Hospital Association News, April 29, 2013 Free full text
5 Statement on FOSAMAX (alendronate sodium) Product Liability Trial Merck, March 12, 2013 Free full text
6 FDA alerts providers to drug product recalls American Hospital Association News, March 29, 2013 Free full text
7 Taro Receives FDA Approval For Topicort (desoximetasone) Topical Spray, 0.25% Taro Pharmaceuticals USA, April 15, 2013 Free full text
8 Alcon announces FDA approval of Simbrinza Suspension, a new beta blocker-free, fixed-combination therapy for glaucoma patients Novartis, April 22, 2013 Free full text
9 U.S. FDA Approves INVOKANA (Canagliflozin) to Treat Adults with Type 2 Diabetes Janssen, April 1, 2013 Free full text
10 CryoLife Receives FDA Clearance For Next Generation HeRO Device CryoLife, April 5, 2013 Free full text
11 US District Court rules one PULMICORT RESPULES (budesonide inhalation suspension) patent invalid and another patent not infringed AstraZeneca, April 2, 2013 Free full text
12 FDA approves Diclegis for pregnant women experiencing nausea and vomiting FDA Press Announcements, April 12, 2013 Free full text
13 CEL-SCI Corporation Provides Update on Phase III Clinical Trial CEL-SCI, April 24, 2013 Free full text
14 Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure Astellas, April 16, 2013 Free full text
15 Pfizer Issued Warning Letter for Italian Manufacturing Plant BioPharm International, April 12, 2013 Free full text
16 Valeant Pharmaceuticals Provides Update to Recent Event Valeant Pharmaceuticals International, April 5, 2013 Free full text
17 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Teva Pharmaceutical Industries, April 9, 2013 Free full text
18 Astellas pharma us, inc. names new president Astellas, April 3, 2013 Free full text
19 Medivation and astellas provide update on prevail Astellas, April 5, 2013 Free full text
20 Study: Tablets Can Effectively Read EEG Results Healthcare Informatics, April 5, 2013 Free full text
Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close